

Founded: 2009 (Rouen, France)
Product: R-One robotic platform for interventional cardiology (CE marked 2019)
Clinical performance: R-One demonstrated >95% technical procedure success in clinical studies
Geographic presence: Deployed across Europe, Africa and China; NMPA approval in China (Dec 8, 2023)
Notable funding: Series C €40M led by MicroPort (Apr 29, 2020); debt financing Dec 16, 2021 (European Investment Bank involved)
Interventional cardiology / vascular intervention
2009
Medical devices / Medical robotics
€40M
€5M
Participating investors included GO CAPITAL, NCI, Normandie Participations, M Capital, Supernova Invest, and regional banks/funds